"pulmonary fibrosis" trang 5 - tải miễn phí từ tailieunhanh
Mechanical ventilation in idiopathic pulmonary fibrosis: A nationwide analysis of ventilator use, outcomes, and resource burden

Mechanical ventilation in idiopathic pulmonary fibrosis: A nationwide analysis of ventilator use, outcomes, and resource burden
9    54    1
Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: A retrospective single-center study

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: A retrospective single-center study
8    37    1
Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: A prospective observational study

Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: A prospective observational study
7    26    1
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries

Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries
12    45    1
Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen

Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
9    13    1
Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America

Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America
7    16    1
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: Analysis from the Australian IPF registry

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: Analysis from the Australian IPF registry
8    29    1
Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells
13    48    1
Study protocol: Exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebocontrolled, multi-center phase III trial (EXAFIP)

Study protocol: Exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebocontrolled, multi-center phase III trial (EXAFIP)
8    42    1
Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/ mTOR and hedgehog signalling via increasing miR-193a expression

Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/ mTOR and hedgehog signalling via increasing miR-193a expression
16    51    1
IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study

IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study
8    39    1
Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
8    34    1
Pulmonary fibrosis in dyskeratosis congenita: A case report with a PRISMA-compliant systematic review

Pulmonary fibrosis in dyskeratosis congenita: A case report with a PRISMA-compliant systematic review
10    11    1
Clinical characteristics and outcomes in adult cystic fibrosis patients with severe lung disease in Porto Alegre, southern Brazil

Clinical characteristics and outcomes in adult cystic fibrosis patients with severe lung disease in Porto Alegre, southern Brazil
8    46    1
Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: Experience of a Brazilian CF Centre

Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: Experience of a Brazilian CF Centre
5    34    1
Symptom prevalence of patients with fibrotic interstitial lung disease: A systematic literature review

Symptom prevalence of patients with fibrotic interstitial lung disease: A systematic literature review
11    66    1
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
12    40    1
Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis

Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
10    41    1
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report
5    37    1
Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
8    38    1